Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations | |
XU Ling[1]; LU Yu Hong[2]; LAI Jing[1,2]; YU Wei[3]; ZHANG Yi Kai[1]; JIN Zhen Yi[1]; XU Yan[1,4]; CHEN Jie[2]; ZHA Xian Feng[5]; CHEN Shao Hua[1] | |
2015 | |
卷号 | 0期号:12页码:1276 |
关键词 | 慢性粒细胞白血病 TCR 患者 突变 耐药 ABL 反转录聚合酶链反应 T细胞受体 |
URL标识 | 查看原文 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4742566 |
专题 | 暨南大学 |
作者单位 | 1.[1]Institute of Hematology, Jinan University, Guangzhou 510632, China 2.[2]Department of Hematology, First Affiliated Hospital, Jinan University, Guangzhou 510632, China 3.[3]Department of Hematology, Guangzhou No. 12 People's Hospital, Guangzhou 510632, China 4.[4]Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou 510632, China 5.[5]Department of clinical laboratory, First Affiliated Hospital, Jinan University, Guangzhou 510632, China |
推荐引用方式 GB/T 7714 | XU Ling[1],LU Yu Hong[2],LAI Jing[1,2],et al. Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations[J],2015,0(12):1276. |
APA | XU Ling[1].,LU Yu Hong[2].,LAI Jing[1,2].,YU Wei[3].,ZHANG Yi Kai[1].,...&LI Yang Qiu[1,2,4].(2015).Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations.,0(12),1276. |
MLA | XU Ling[1],et al."Characteristics of the TCR Vβ repertoire in imatinib-resistant chronic myeloid leukemia patients with ABL mutations".0.12(2015):1276. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论